Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis

Brain and Behavior

Volumn 3, Issue 2, 2013, Pages 145-158

  Casas, Caty ^a   Herrando Grabulosa, Mireia ^a   Manzano, Raquel ^b   Mancuso, Renzo ^a   Osta, Rosario ^b   Navarro, Xavier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Amyotrophic lateral sclerosis; ChAT; MHC I; Motoneuron; Presynaptic boutons; Tdp 43

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CHOLINE ACETYLTRANSFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SIGMA 1 OPIATE RECEPTOR; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHOLINERGIC DYSFUNCTION; CONTROLLED STUDY; DENERVATION; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE; IMMUNOHISTOCHEMISTRY; LUMBAR SPINAL CORD; MICROGLIA; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENSHAW CELL; SOD1G93A GENE; SPINAL CORD MOTONEURON;

EID: 84888172861     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.104     Document Type: Article

References (50)

1. Alves, C. J., L. P. de Santana, A. J. dos Santos, G. P. de Oliveira, T. Duobles, J. M. Scorisa, et al. 2011. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res. 1394:90-104.
2. Arvidsson, U., M. Riedl, R. Elde, and B. Meister, 1997. Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J. Comp. Neurol. 378:454-467.
3. Barber, R. P., P. E. Phelps, C. R. Houser, G. D. Crawford, P. M. Salvaterra, and J. E. Vaughn, 1984. The morphology and distribution of neurons containing choline acetyltransferase in the adult rat spinal cord: an immunocytochemical study. J. Comp. Neurol. 229:329-346.
4. Basso, M., G. Samengo, G. Nardo, T. Massignan, G. D'Alessandro, S. Tartari, et al. 2009. Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis. PLoS ONE 4:e8130.
5. Blinzinger, K., and G. Kreutzberg, 1968. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z. Zellforsch. Mikrosk. Anat. 85:145-157.
6. Bo, L., S. Mork, P. A. Kong, H. Nyland, C. A. Pardo, and B. D. Trapp, 1994. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J. Neuroimmunol. 51:135-146.
7. Bosco, D. A., G. Morfini, N. M. Karabacak, Y. Song, F. Gros-Louis, P. Pasinelli, et al. 2010. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 13:1396-1403.
8. Buratti, E., L. De Conti, C. Stuani, M. Romano, M. Baralle, and F. Baralle, 2010. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 277:2268-2281.
9. de Carvalho, M., and M. Swash, 2011. Amyotrophic lateral sclerosis: an update. Curr. Opin. Neurol. 24:497-503.
10. Chang, Q., and L. J. Martin, 2009. Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: a quantitative confocal analysis. Am. J. Pathol. 174:574-585.
11. Chiu, A. Y., P. Zhai, M. C. Dal Canto, T. M. Peters, Y. W. Kwon, S. M. Prattis, et al. 1995. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6:349-362.
12. Cleveland, D. W., and J. D. Rothstein, 2001. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2:806-819.
13. Crochemore, C., E. Pena-Altamira, M. Virgili, B. Monti, and A. Contestabile, 2005. Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice. Neurochem. Int. 46:357-368.
14. Cullheim, S., J. O. Kellerth, and S. Conradi, 1977. Evidence for direct synaptic interconnections between cat spinal alpha-motoneurons via the recurrent axon collaterals: a morphological study using intracellular injection of horseradish peroxidase. Brain Res. 132:1-10.
15. Dadon-Nachum, M., E. Melamed, and D. Offen, 2011. The "dying-back" phenomenon of motor neurons in ALS. J. Mol. Neurosci. 43:470-477.
16. Fischer, L. R., D. G. Culver, P. Tennant, A. A. Davis, M. Wang, A. Castellano-Sanchez, et al. 2004. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185:232-240.
17. Gurney, M. E., H. Pu, A. Y. Chiu, M. C. Dal Canto, C. Y. Polchow, D. D. Alexander, et al. 1994. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264:1772-1775.
18. Hennig, R., and T. Lomo, 1985. Firing patterns of motor units in normal rats. Nature 314:164-166.
19. Huh, G. S., L. M. Boulanger, H. Du, P. A. Riquelme, T. M. Brotz, and C. J. Shatz, 2000. Functional requirement for class I MHC in CNS development and plasticity. Science 290:2155-2159.
20. Ikemoto, A., S. Nakamura, I. Akiguchi, and A. Hirano, 2002. Differential expression between synaptic vesicle proteins and presynaptic plasma membrane proteins in the anterior horn of amyotrophic lateral sclerosis. Acta Neuropathol. 103:179-187.
21. Kato, T. 1989. Choline acetyltransferase activities in single spinal motor neurons from patients with amyotrophic lateral sclerosis. J. Neurochem. 52:636-640.
22. Kitzman, P. 2006. Changes in vesicular glutamate transporter 2, vesicular GABA transporter and vesicular acetylcholine transporter labeling of sacrocaudal motoneurons in the spastic rat. Exp. Neurol. 197:407-419.
23. Kuo, J. J., M. Schonewille, T. Siddique, A. N. Schults, R. Fu, P. R. Bar, et al. 2004. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. J. Neurophysiol. 91:571-575.
24. Lagerback, P. A., L. O. Ronnevi, S. Cullheim, and J. O. Kellerth, 1981. An ultrastructural study of the synaptic contacts of alpha 1-motoneuron axon collaterals. II. Contacts in lamina VII. Brain Res. 222:29-41.
25. Lagier-Tourenne, C., and D. W. Cleveland, 2010. Neurodegeneration: an expansion in ALS genetics. Nature 466:1052-1053.
26. Luty, A. A., J. B. Kwok, C. Dobson-Stone, C. T. Loy, K. G. Coupland, H. Karlstrom, et al. 2010. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann. Neurol. 68:639-649.
27. Mancuso, R., E. Santos-Nogueira, R. Osta, and X. Navarro, 2011. Electrophysiological analysis of a murine model of motoneuron disease. Clin. Neurophysiol. 122:1660-1670.
28. Matsumoto, S., S. Goto, H. Kusaka, H. Ito, and T. Imai, 1994. Synaptic pathology of spinal anterior horn cells in amyotrophic lateral sclerosis: an immunohistochemical study. J. Neurol. Sci. 125:180-185.
29. Mavlyutov, T. A., M. L. Epstein, K. A. Andersen, L. Ziskind-Conhaim, and A. E. Ruoho, 2010. The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience 167:247-255.
30. Miles, G. B., R. Hartley, A. J. Todd, and R. M. Brownstone, 2007. Spinal cholinergic interneurons regulate the excitability of motoneurons during locomotion. Proc. Natl. Acad. Sci. USA 104:2448-2453.
31. Moreno-Lopez, B., C. R. Sunico, and D. Gonzalez-Forero, 2011. NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism. Mol. Neurobiol. 43:41-66.
32. Murray, L. M., K. Talbot, T. H. Gillingwater, 2010. Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol. Appl. Neurobiol. 36:133-156.
33. Nagao, M., H. Misawa, S. Kato, and S. Hirai, 1998. Loss of cholinergic synapses on the spinal motor neurons of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 57:329-333.
34. Nagy, J. I., T. Yamamoto, and L. M. Jordan, 1993. Evidence for the cholinergic nature of C-terminals associated with subsurface cisterns in alpha-motoneurons of rat. Synapse 15:17-32.
35. Oda, Y. 1999. Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol. Int. 49:921-937.
36. Oda, Y., S. Imai, I. Nakanishi, T. Ichikawa, and T. Deguchi, 1995. Immunohistochemical study on choline acetyltransferase in the spinal cord of patients with amyotrophic lateral sclerosis. Pathol. Int. 45:933-939.
37. Penas, C., C. Casas, I. Robert, J. Fores, and X. Navarro, 2009. Cytoskeletal and activity-related changes in spinal motoneurons after root avulsion. J. Neurotrauma 26:763-779.
38. Pieri, M., F. Albo, C. Gaetti, A. Spalloni, C. P. Bengtson, P. Longone, et al. 2003. Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci. Lett. 351:153-156.
39. Pun, S., A. F. Santos, S. Saxena, L. Xu, and P. Caroni, 2006. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9:408-419.
40. Ray, K., S. E. Perez, Z. Yang, J. Xu, B. W. Ritchings, H. Steller, et al. 1999. Kinesin-II is required for axonal transport of choline acetyltransferase in Drosophila. J. Cell Biol. 147:507-518.
41. Raynor, E. M., and J. M. Shefner, 1994. Recurrent inhibition is decreased in patients with amyotrophic lateral sclerosis. Neurology 44:2148-2153.
42. Reid, B., C. R. Slater, and G. S. Bewick, 1999. Synaptic vesicle dynamics in rat fast and slow motor nerve terminals. J. Neurosci. 19:2511-2521.
43. Sasaki, S., and S. Maruyama, 1994. Decreased synaptophysin immunoreactivity of the anterior horns in motor neuron disease. Acta Neuropathol. 87:125-128.
44. Saxena, S., E. Cabuy, and P. Caroni, 2009. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 12:627-636.
45. Schutz, B. 2005. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis. Neurobiol. Dis. 20:131-140.
46. Tateno, M., S. Kato, T. Sakurai, N. Nukina, R. Takahashi, and T. Araki, 2009. Mutant SOD1 impairs axonal transport of choline acetyltransferase and acetylcholine release by sequestering KAP3. Hum. Mol. Genet. 18:942-955.
47. Thams, S., A. Oliveira, and S. Cullheim, 2008. MHC class I expression and synaptic plasticity after nerve lesion. Brain Res. Rev. 57:265-269.
48. Virgo, L., J. de Belleroche, M. Rossi, and T. J. Steiner, 1992. Characterisation of the distribution of choline acetyltransferase messenger RNA in human spinal cord and its depletion in motor neurone disease. J. Neurol. Sci. 112:126-132.
49. Wang, W., P. M. Salvaterra, S. Loera, and A. Y. Chiu, 1997. Brain-derived neurotrophic factor spares choline acetyltransferase mRNA following axotomy of motor neurons in vivo. J. Neurosci. Res. 47:134-143.
50. Zagoraiou, L., T. Akay, J. F. Martin, R. M. Brownstone, T. M. Jessell, and G. B. Miles, 2009. A cluster of cholinergic premotor interneurons modulates mouse locomotor activity. Neuron 64:645-662.